New antibody drug aims to rally immune system against Hard-to-Treat cancers
Disease control
Recruiting now
This early-stage trial is testing a new drug called BA3182 in 168 people with advanced adenocarcinoma, a type of cancer that has spread and cannot be removed by surgery. The drug is a bispecific antibody designed to bring immune cells close to cancer cells so they can be destroye…
Phase: PHASE1 • Sponsor: BioAtla, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC